-
1.
公开(公告)号:US12098368B2
公开(公告)日:2024-09-24
申请号:US17737880
申请日:2022-05-05
申请人: Cepheid
发明人: Russell Higuchi
IPC分类号: C12Q1/68 , C12N15/11 , C12P19/34 , C12Q1/6876
CPC分类号: C12N15/11 , C12P19/34 , C12Q1/6876 , C12N2310/321 , C12N2310/333 , C12N2310/334 , C12N2310/335 , C12N2310/336 , C12N2310/531
摘要: Described herein are methods and compositions that provide highly efficient nucleic acid amplification. In some embodiments, this allows a 3-fold or greater increase of amplification product for each amplification cycle and therefore increased sensitivity and speed over conventional PCR. Modified bases can be employed in primers to provide this base-3 or greater amplification with satisfactory PCR cycle times, which are improved, as compared to those observed in the absence of modified bases.
-
公开(公告)号:US20240175089A1
公开(公告)日:2024-05-30
申请号:US18485615
申请日:2023-10-12
申请人: Cepheid
IPC分类号: C12Q1/6886
CPC分类号: C12Q1/6886 , C12Q2600/158 , C12Q2600/16 , C12Q2600/166
摘要: Compositions and methods for detecting bladder cancer are provided. In some embodiments, methods of monitoring recurrence of bladder cancer are provided. In some embodiments, the methods comprise detecting a set of markers consisting of CRH, IGF2, KRT20, and ANXA10.
-
公开(公告)号:US11952621B2
公开(公告)日:2024-04-09
申请号:US17306761
申请日:2021-05-03
申请人: Cepheid
发明人: Russell Higuchi
CPC分类号: C12Q1/686 , C12Q2525/155 , C12Q2525/161 , C12Q2525/191 , C12Q2531/119 , C12Q1/686 , C12Q2525/155 , C12Q2525/161 , C12Q2525/191 , C12Q2531/119
摘要: Described herein are methods and compositions that provide highly efficient nucleic acid amplification. In some embodiments, this allows a greater than 2-fold increase of amplification product for each amplification cycle and therefore increased sensitivity and speed over conventional PCR.
-
公开(公告)号:US20210403981A1
公开(公告)日:2021-12-30
申请号:US17240865
申请日:2021-04-26
申请人: Cepheid
发明人: Russell Higuchi , Sergey G. Lokhov , Victoria Le , Benjamin Pavlik , Gongbo Wang
IPC分类号: C12Q1/686 , C12Q1/6853
摘要: Described herein are methods and compositions that provide highly efficient nucleic acid amplification and signal detection using a cycling probe. In some embodiments, this allows a 3-fold or greater increase of amplification product for each amplification cycle and therefore increased sensitivity and speed over conventional PCR. Modified bases can be employed in primers to provide this base-3 or greater amplification with satisfactory PCR cycle times, which are improved, as compared to those observed in the absence of modified bases.
-
5.
公开(公告)号:US20200239878A1
公开(公告)日:2020-07-30
申请号:US16667446
申请日:2019-10-29
申请人: Cepheid
发明人: Russell Higuchi
IPC分类号: C12N15/11 , C12P19/34 , C12Q1/6876
摘要: Described herein are methods and compositions that provide highly efficient nucleic acid amplification. In some embodiments, this allows a 3-fold or greater increase of amplification product for each amplification cycle and therefore increased sensitivity and speed over conventional PCR. Modified bases can be employed in primers to provide this base-3 or greater amplification with satisfactory PCR cycle times, which are improved, as compared to those observed in the absence of modified bases.
-
公开(公告)号:US11260387B2
公开(公告)日:2022-03-01
申请号:US15839731
申请日:2017-12-12
申请人: Cepheid
发明人: Edwin Wei-Lung Lai , Andrew Kohlway , Reuel Van Atta , Russell Higuchi , Alexander A. Gall , Kriszten Kocmond
IPC分类号: B01L3/00 , B01L7/00 , C12Q1/6827 , C12N15/10 , C12Q1/6853 , C12Q1/686
摘要: Methods of determining methylation of DNA are provided. In one illustrative, but non-limiting embodiment the method comprises i) contacting a biological sample comprising a nucleic acid to a first matrix material comprising a first column or filter where said matrix material binds and/or filters nucleic acids in said sample and thereby purifies the DNA; ii) eluting the bound DNA from the first matrix material and denaturing the DNA to produce eluted denatured DNA; iii) heating the eluted DNA in the presence of bisulfite ions to produce a deaminated nucleic acid; iv) contacting said deaminated nucleic acid to a second matrix material comprising a second column to bind said deaminated nucleic acid to said second matrix material; v) desulphonating the bound deaminated nucleic acid and/or simultaneously eluting and desulphonating the nucleic acid by contacting the deaminated nucleic acid with an alkaline solution to produce a bisulfite converted nucleic acid; vi) eluting said bisulfite converted nucleic acid from said second matrix material; and vii) performing methylation specific PCR and/or nucleic acid sequencing, and/or high resolution melting analysis (HRM) on said bisulfite-converted nucleic acid to determine the methylation of said nucleic acid, wherein at least steps iv) through vi) are performed in a single reaction cartridge.
-
公开(公告)号:US20210395797A1
公开(公告)日:2021-12-23
申请号:US17306761
申请日:2021-05-03
申请人: Cepheid
发明人: Russell Higuchi
IPC分类号: C12Q1/686
摘要: Described herein are methods and compositions that provide highly efficient nucleic acid amplification. In some embodiments, this allows a greater than 2-fold increase of amplification product for each amplification cycle and therefore increased sensitivity and speed over conventional PCR.
-
公开(公告)号:US11028434B2
公开(公告)日:2021-06-08
申请号:US16359947
申请日:2019-03-20
申请人: Cepheid
发明人: Russell Higuchi
摘要: Described herein are methods and compositions that provide highly efficient nucleic acid amplification. In some embodiments, this allows a greater than 2-fold increase of amplification product for each amplification cycle and therefore increased sensitivity and speed over conventional PCR.
-
公开(公告)号:US20240287618A1
公开(公告)日:2024-08-29
申请号:US18646986
申请日:2024-04-26
申请人: Cepheid
IPC分类号: C12Q1/6886
CPC分类号: C12Q1/6886 , C12Q2600/106 , C12Q2600/158
摘要: Compositions and methods for detecting bladder cancer are provided. In some embodiments, methods of detecting low grade bladder cancer are provided. In some embodiments, methods of monitoring recurrence of bladder cancer are provided. In some embodiments, the methods comprise detecting androgen receptor (AR) and/or uroplakin 1B (UPK1B).
-
公开(公告)号:US12000001B2
公开(公告)日:2024-06-04
申请号:US16411485
申请日:2019-05-14
申请人: Cepheid
IPC分类号: C12Q1/6886
CPC分类号: C12Q1/6886 , C12Q2600/106 , C12Q2600/158
摘要: Compositions and methods for detecting bladder cancer are provided. In some embodiments, methods of detecting low grade bladder cancer are provided. In some embodiments, methods of monitoring recurrence of bladder cancer are provided. In some embodiments, the methods comprise detecting androgen receptor (AR) and/or uroplakin 1B (UPK1B).
-
-
-
-
-
-
-
-
-